Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lene Heickendorff

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 19, 2007
Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish populationPeter H Nissen, Signe E Christensen, Lene Heickendorff, et al.
European Journal of Endocrinology|May 1, 2002
Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to plasma parathyroid hormone and calcium and phosphate metabolismLars Rejnmark, Anna L Lauridsen, Peter Vestergaard, et al.
Ugeskrift for Laeger|April 6, 2019
[Infrastructure of clinical support and research in the Danish national genome centre]Torben F Ørntoft, Søren Brunak, Cathrine Jespergaard, et al.
Langenbeck'S Archives of Surgery|November 8, 2012
BMD improvements after operation for primary hyperparathyroidismLars Rolighed, Peter Vestergaard, Lene Heickendorff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2009
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control studyLars Rejnmark, Anna Tietze, Peter Vestergaard, et al.
Clinical Endocrinology|April 16, 2008
Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methodsSigne Engkjaer Christensen, Peter H Nissen, Peter Vestergaard, et al.
European Journal of Endocrinology|February 4, 2015
No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
Clinical Endocrinology|November 17, 2009
Multiplex ligation-dependent probe amplification (MLPA) screening for exon copy number variation in the calcium sensing receptor gene: no large rearrangements identified in patients with calcium metabolic disordersPeter H Nissen, Signe E Christensen, Andrew Wallace, et al.
Thrombosis Research|April 18, 2002
Prospective evaluation of the quality of oral anticoagulation management in an outpatient clinic and in general practicesTomas Holm, Susanna Deutch, Jens F Lassen, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Endocrinology and Metabolism|August 19, 2007
Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish populationPeter H Nissen, Signe E Christensen, Lene Heickendorff, et al.
European Journal of Endocrinology|May 1, 2002
Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to plasma parathyroid hormone and calcium and phosphate metabolismLars Rejnmark, Anna L Lauridsen, Peter Vestergaard, et al.
Ugeskrift for Laeger|April 6, 2019
[Infrastructure of clinical support and research in the Danish national genome centre]Torben F Ørntoft, Søren Brunak, Cathrine Jespergaard, et al.
Langenbeck'S Archives of Surgery|November 8, 2012
BMD improvements after operation for primary hyperparathyroidismLars Rolighed, Peter Vestergaard, Lene Heickendorff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2009
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control studyLars Rejnmark, Anna Tietze, Peter Vestergaard, et al.
Clinical Endocrinology|April 16, 2008
Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methodsSigne Engkjaer Christensen, Peter H Nissen, Peter Vestergaard, et al.
European Journal of Endocrinology|February 4, 2015
No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
Clinical Endocrinology|November 17, 2009
Multiplex ligation-dependent probe amplification (MLPA) screening for exon copy number variation in the calcium sensing receptor gene: no large rearrangements identified in patients with calcium metabolic disordersPeter H Nissen, Signe E Christensen, Andrew Wallace, et al.
Thrombosis Research|April 18, 2002
Prospective evaluation of the quality of oral anticoagulation management in an outpatient clinic and in general practicesTomas Holm, Susanna Deutch, Jens F Lassen, et al.
Pageof 7